This is a Phase 1 randomized, placebo-controlled, modified double-blinded clinical trial designed to evaluate the safety and immunogenicity of a HIV vaccine called FLSC (full length single chain) in healthy volunteers without HIV infection. This novel vaccine was developed by investigators at the Institute of Human Virology as a strategy to help prevent HIV infection. Volunteers must be healthy, 18-45 years of age, HIV negative, and have never previously participated in an HIV or DNA vaccine trial. Compensation given for travel and expenses.
Contact: Amy Nelson, RN (410) 706-1684
Clinical trials are studies designed to find new and better ways to treat patients. Through clinical trials, scientists and physicians at the Institute of Human Virology have broken new ground in the development of treatments.
Institute of Human Virology
725 w. Lombard St.
Baltimore, Md. 21201
To enroll in a study call 410-706-0100 or toll free 1-866-448-4448.